These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24614632)

  • 1. [Pharmacological study of the amerliorative effects of Yokukansan on memory impairment and the behavioral and psychological symptoms of dementia in AD models].
    Kubota K; Nogami A; Takasaki K; Katsurabayashi S; Mishima K; Fujiwara M; Iwasaki K
    Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):110-4. PubMed ID: 24614632
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological studies for the ameliorative effects of yokukansan on memory deficits and abnormal behavior in an animal model of dementia].
    Iwasaki K; Takasaki K; Nogami A; Kubota K; Katsurabayashi S; Mishima K; Fujiwara M
    Nihon Yakurigaku Zasshi; 2012 Aug; 140(2):66-70. PubMed ID: 22878569
    [No Abstract]   [Full Text] [Related]  

  • 3. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
    J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats.
    Ikarashi Y; Iizuka S; Imamura S; Yamaguchi T; Sekiguchi K; Kanno H; Kawakami Z; Yuzurihara M; Kase Y; Takeda S
    Biol Pharm Bull; 2009 Oct; 32(10):1701-9. PubMed ID: 19801831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Japanese Angelica acutiloba root and yokukansan increase hippocampal acetylcholine level, prevent apoptosis and improve memory in a rat model of repeated cerebral ischemia.
    Nogami-Hara A; Nagao M; Takasaki K; Egashira N; Fujikawa R; Kubota K; Watanabe T; Katsurabayashi S; Hatip FB; Hatip-Al-Khatib I; Iwasaki K
    J Ethnopharmacol; 2018 Mar; 214():190-196. PubMed ID: 29269276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical syndrome of Alzheimer's disease: aspects particularly relevant to clinical trials.
    Mohs RC
    Genes Brain Behav; 2005 Apr; 4(3):129-33. PubMed ID: 15810901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic involvement and synaptic dynamin 1 expression in Yokukansan-mediated improvement of spatial memory in a rat model of early Alzheimer's disease.
    Uchida N; Takasaki K; Sakata Y; Nogami A; Oishi H; Watanabe T; Shindo T; Egashira N; Kubota K; Katsurabayashi S; Mishima K; Fujiwara M; Nishimura R; Iwasaki K
    Phytother Res; 2013 Jul; 27(7):966-72. PubMed ID: 22888033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ameliorative effects of yokukansan on learning and memory deficits in olfactory bulbectomized mice.
    Yamada M; Hayashida M; Zhao Q; Shibahara N; Tanaka K; Miyata T; Matsumoto K
    J Ethnopharmacol; 2011 Jun; 135(3):737-46. PubMed ID: 21513784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease.
    Furukawa K; Tomita N; Uematsu D; Okahara K; Shimada H; Ikeda M; Matsui T; Kozaki K; Fujii M; Ogawa T; Umegaki H; Urakami K; Nomura H; Kobayashi N; Nakanishi A; Washimi Y; Yonezawa H; Takahashi S; Kubota M; Wakutani Y; Ito D; Sasaki T; Matsubara E; Une K; Ishiki A; Yahagi Y; Shoji M; Sato H; Terayama Y; Kuzuya M; Araki N; Kodama M; Yamaguchi T; Arai H
    Geriatr Gerontol Int; 2017 Feb; 17(2):211-218. PubMed ID: 26711658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yokukansan, a traditional Japanese medicine, ameliorates memory disturbance and abnormal social interaction with anti-aggregation effect of cerebral amyloid β proteins in amyloid precursor protein transgenic mice.
    Fujiwara H; Takayama S; Iwasaki K; Tabuchi M; Yamaguchi T; Sekiguchi K; Ikarashi Y; Kudo Y; Kase Y; Arai H; Yaegashi N
    Neuroscience; 2011 Apr; 180():305-13. PubMed ID: 21303686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration in brain-derived neurotrophic factor (BDNF) after treatment of mice with herbal mixture containing Euphoria longana, Houttuynia cordata and Dioscorea japonica.
    Jeon S; Lee CH; Liu QF; Kim GW; Koo BS; Pak SC
    Daru; 2014 Nov; 22(1):77. PubMed ID: 25431319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kamikihito improves memory dysfunction in Alzheimer's disease].
    Tohda C; Watari H
    Nihon Yakurigaku Zasshi; 2015 May; 145(5):224-8. PubMed ID: 25958908
    [No Abstract]   [Full Text] [Related]  

  • 13. Gami-Chunghyuldan ameliorates memory impairment and neurodegeneration induced by intrahippocampal Aβ 1-42 oligomer injection.
    Choi JG; Moon M; Kim HG; Mook-Jung I; Chung SY; Kang TH; Kim SY; Lee EH; Oh MS
    Neurobiol Learn Mem; 2011 Sep; 96(2):306-14. PubMed ID: 21689771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.
    Monji A; Takita M; Samejima T; Takaishi T; Hashimoto K; Matsunaga H; Oda M; Sumida Y; Mizoguchi Y; Kato T; Horikawa H; Kanba S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):308-11. PubMed ID: 19138715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory Impairment, Dementia, and Alzheimer's Disease in Classical and Contemporary Traditional Chinese Medicine.
    May BH; Feng M; Zhou IW; Chang SY; Lu SC; Zhang AL; Guo XF; Lu CJ; Xue CC
    J Altern Complement Med; 2016 Sep; 22(9):695-705. PubMed ID: 27464225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kamikihi-to (KKT) rescues axonal and synaptic degeneration associated with memory impairment in a mouse model of Alzheimer's disease, 5XFAD.
    Tohda C; Nakada R; Urano T; Okonogi A; Kuboyama T
    Int J Neurosci; 2011 Dec; 121(12):641-8. PubMed ID: 21770858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
    Liu Y; Hua Q; Lei H; Li P
    J Ethnopharmacol; 2011 Sep; 137(2):1035-46. PubMed ID: 21798326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ameliorative effects of yokukansan on behavioral deficits in a gerbil model of global cerebral ischemia.
    Liu Y; Nakamura T; Toyoshima T; Lu F; Sumitani K; Shinomiya A; Keep RF; Yamamoto T; Tamiya T; Itano T
    Brain Res; 2014 Jan; 1543():300-7. PubMed ID: 24269335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardized Herbal Formula PM012 Decreases Cognitive Impairment and Promotes Neurogenesis in the 3xTg AD Mouse Model of Alzheimer's Disease.
    Ye M; Chung HS; An YH; Lim SJ; Choi W; Yu AR; Kim JS; Kang M; Cho S; Shim I; Bae H
    Mol Neurobiol; 2016 Oct; 53(8):5401-12. PubMed ID: 26446019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.